Ocular Therapeutix
OCUL
OCUL
130 hedge funds and large institutions have $178M invested in Ocular Therapeutix in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 36 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more funds holding
Funds holding: 123 → 130 (+7)
1% more capital invested
Capital invested by funds: $176M → $178M (+$1.57M)
2.14% less ownership
Funds ownership: 57.71% → 55.57% (-2.1%)
Holders
130
Holding in Top 10
3
Calls
$2.27M
Puts
$1.38M
Top Buyers
| 1 | +$2.68M | |
| 2 | +$2.47M | |
| 3 | +$1.53M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.33M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.33M |
Top Sellers
| 1 | -$4.09M | |
| 2 | -$1.97M | |
| 3 | -$1.85M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.72M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.67M |